Biomedical Textiles Market worth $20.7 billion by 2027 | Key players Royal DSM, Covidien, Johnson & Johnson, Smith & Nephew, Cardinal Health.

According to recent market research the "Biomedical Textiles Market by Fiber Type (Non-Biodegradable, Biodegradable), Fabric Type (Non-Woven, Woven), Application (Non-Implantable, Surgical Sutures), and Region (North America, Europe, APAC, MEA, South America) - Global Forecast to 2027", was worth USD 15.2 billion in 2022 and is expected to be worth USD 20.7 billion by 2027, growing at a 6.3% CAGR during the forecast period. The rising number of surgeries, rapidly aging population, and increased healthcare spending in emerging economies are expected to drive the biomedical textiles market during the forecast period.

Browse 297 market data Tables and 55 Figures spread through 245 Pages and in-depth TOC on "Biomedical Textiles Market - Global Forecast to 2027"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/biomedical-textile-market-231997196.html

Non-biodegradable fiber is absorbed by the body gradually and takes more than six months to degrade. It is used mainly in high-support bandages, compression bandages, orthopedic bandages, and plasters. Nonbiodegradable fiber can be woven, non-woven, knitted, or braided. Polypropylene and polyethylene are lightweight synthetic fibers made from monomers obtained from naphtha that produces a greater volume of flat and porous fibers. Polypropylene and polyethylene are the lightest of all fibers. They are used in implants such as surgical sutures, artificial tendons, artificial cartilages, artificial joints/bones, and other such orthopedic implants.

Three major fabrics are used as reinforcements for Biomedical textiles-non-woven, woven, and other fabrics. According to EDANA, the international association for non-woven fabric and related industries, non-woven is a unique, high-tech, and engineered fabric used across a wide range of applications and products. This fabric is commonly characterized by the manufacturing process, including dry laid, wet laid, spun melt, and others. Different manufacturing processes are used to manufacture products to achieve the desired characteristics. Non-woven fabric is widely used in non-implantable applications such as bandages. It is also used for orthopaedic bandages and artificial skin applications. Non-woven fabric is used as an alternative to traditional textiles owing to its excellent absorption properties, softness, smoothness, strength, stretchability, comfort and fit, and cost-effectiveness.

Biomedical textiles are used in a variety of applications such as non-implantable, surgical sutures, and others including implantable and extracorporeal devices. The non-implantable application includes bandages, whereas surgical sutures are used for wound closures. The non-implantable application is expected to be the largest and the fastest-growing application of biomedical textiles during the forecast period.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231997196

Bandages protect wounds from trauma, bacteria, and dirt; absorb fluid from wounds; and maintain moist environments to accelerate healing. Bandages are segmented into gauze, adhesive, cohesive, and others. Gauze, the most used bandage, is a thin, woven fabric. It is available in different forms such as rolls, pads, and sponges. Gauze can be used as a primary dressing to cover wounds and allow the penetration of air to improve healing. As a primary dressing, it secures wounds from trauma, absorbs wound fluids, and helps in the debridement of necrotic tissue. It can also be used as a secondary dressing to hold other dressings (mostly advanced wound dressings and active wound care products).

Asia Pacific includes countries such as China, Japan, South Korea, India, Singapore, Australia & New Zealand, and the Rest of Asia Pacific. Asia Pacific houses one of the largest textile industries. The region's strong industrial base in line with the growing population and the rising disposable income has driven the demand for a variety of technical textile products, which, in turn, is expected to support the growth of the market for biomedical textiles in the region. The emerging markets of the Asia Pacific such as China, India, and Singapore are expected to play a major role in the biomedical textiles market of the region.

Some of the key players in the global Biomedical textiles market are such as Royal DSM (Netherlands), Johnson & Johnson (US), Medtronic (US), Cardinal Health (US), Integra LifeSciences Corporation (US), Smith & Nephew (UK), Medline (US), Paul Hartmann AG (Germany), and BSN Medical (Germany).

For more Details Speak to Our Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=231997196

Royal DSM N.V., the key global science-based company is a major player in the biomedical textiles market. The company operates through four business segments, namely, Nutrition, Materials, Innovative Center, and Corporate Activities. It offers various types of food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy, and bio-based materials. It offers its biomedical textile products through its medical subsegment. The company has subsidiaries in five regions and business presence across 19 countries.

Medtronic plc offers biomedical textiles through its subsidiary, Covidien, and develops, manufactures, and distributes healthcare products. In 2015, Covidien was acquired by Medtronic (Ireland). Medtronic operates through its four business segments-Cardiovascular, Medical Surgical, Neuroscience, and Diabetes. The company offers biomedical textiles under its Cardiac and Vascular Group and Medical Surgical business segments. Medtronic has presence in the Middle East, Europe, Asia Pacific, and the Americas and has 89 manufacturing facilities across the globe. Its subsidiaries include Covidien, Inc. (US), Tyco Healthcare (HKSAR), Ltd. (China), Tyco Healthcare Pte, Ltd. (Taiwan), Tyco Healthcare, Ltd. (Thailand), Covidien Vision Group (Japan), VNUS Medical Technologies, Inc. (US), Valleylab, Inc. (US), and Power Medical Interventions, Inc. (US).

Contact:

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: newsletter@marketsandmarkets.com
Press Release: https://www.marketsandmarkets.com/PressReleases/biomedical-textile.asp
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/biomedical-textile-market.asp

About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.